Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 658

1.

Prospective Implementation of the Ottawa Subarachnoid Hemorrhage Rule and 6-Hour Computed Tomography Rule.

Perry JJ, Sivilotti MLA, Émond M, Hohl CM, Khan M, Lesiuk H, Abdulaziz K, Wells GA, Stiell IG.

Stroke. 2019 Dec 6:STROKEAHA119026969. doi: 10.1161/STROKEAHA.119.026969. [Epub ahead of print]

PMID:
31805846
2.

Periprocedural Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention Following Fibrinolysis for ST-Segment Elevation Myocardial Infarction.

Rashid MK, Singh K, Bernick J, Wells GA, Hibbert B, Russo J, So DY, Le May MR; CAPITAL PCI Group.

J Invasive Cardiol. 2019 Dec;31(12):E387-E391.

3.

Journal Initiatives to Enhance Preclinical Research: Analyses of Stroke, Nature Medicine, Science Translational Medicine.

Ramirez FD, Jung RG, Motazedian P, Perry-Nguyen D, Di Santo P, MacDonald Z, Clancy AA, Labinaz A, Promislow S, Simard T, Provencher S, Bonnet S, Graham ID, Wells GA, Hibbert B.

Stroke. 2019 Nov 13:STROKEAHA119026564. doi: 10.1161/STROKEAHA.119.026564. [Epub ahead of print]

PMID:
31718504
4.

Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.

Essebag V, Healey JS, Joza J, Nery PB, Kalfon E, Leiria TLL, Verma A, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Philippon F, Eikelboom J, Sandhu RK, Sapp J, Leather R, Yung D, Thibault B, Simpson CS, Ahmad K, Toal S, Sturmer M, Kavanagh K, Crystal E, Wells GA, Krahn AD, Birnie DH.

Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007545. doi: 10.1161/CIRCEP.119.007545. Epub 2019 Oct 15.

PMID:
31610718
5.

Performance obligations to improve delivery of hospital-initiated smoking cessation interventions: A before-and-after evaluation.

Mullen KA, Walker KL, Hobler LA, Wells GA, Moroz IA, Pipe AL, Patzer K, Aitken DA, Reid RD.

Nicotine Tob Res. 2019 Sep 30. pii: ntz186. doi: 10.1093/ntr/ntz186. [Epub ahead of print]

PMID:
31563965
6.

Tai Chi for rheumatoid arthritis.

Mudano AS, Tugwell P, Wells GA, Singh JA.

Cochrane Database Syst Rev. 2019 Sep 25;9:CD004849. doi: 10.1002/14651858.CD004849.pub2.

PMID:
31553478
7.

Awareness of hypertension and related factors in northeastern China: a cross-sectional study.

Li T, Song X, Wu J, Li Z, Li L, Yu Y, Wells GA, Liu B.

J Hum Hypertens. 2019 Sep 23. doi: 10.1038/s41371-019-0263-2. [Epub ahead of print]

PMID:
31548618
8.

Agreement between the Cochrane risk of bias tool and Physiotherapy Evidence Database (PEDro) scale: A meta-epidemiological study of randomized controlled trials of physical therapy interventions.

Moseley AM, Rahman P, Wells GA, Zadro JR, Sherrington C, Toupin-April K, Brosseau L.

PLoS One. 2019 Sep 19;14(9):e0222770. doi: 10.1371/journal.pone.0222770. eCollection 2019.

9.

Point of Care Clinical Risk Score to Improve the Negative Diagnostic Utility of an Agatston Score of Zero: Averting the Need for Coronary Computed Tomography Angiography.

Alshahrani AM, Mahmood H, Wells GA, Hossain A, Rybicki FJ, Achenbach S, Al-Mallah MH, Andreini D, Bax JJ, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic JA, Maffei E, Marques H, Pontone G, Raff G, Rubinshtein R, Shaw LJ, Villines TC, Lin FY, Min JK, Chow BJ.

Circ Cardiovasc Imaging. 2019 Sep;12(9):e008737. doi: 10.1161/CIRCIMAGING.118.008737. Epub 2019 Sep 17.

10.

Response by Thiruganasambandamoorthy et al to Letters Regarding Article, "Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope".

Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, McRae AD, Arcot K, Nemnom MJ, Huang L, Mukarram M, Krahn AD, Wells GA, Taljaard M.

Circulation. 2019 Sep 17;140(12):e655-e656. doi: 10.1161/CIRCULATIONAHA.119.041639. Epub 2019 Sep 16. No abstract available.

PMID:
31525105
11.

Protocol for a prospective observational diagnostic study: intraoperative simultaneous limb pressure monitoring (INSTANT) study.

Rockley M, Jetty P, Wells GA.

BMJ Open. 2019 Aug 22;9(8):e030456. doi: 10.1136/bmjopen-2019-030456.

12.

Study protocol: Worldwide comparison of vitamin D status of immigrants from different ethnic origins and native-born populations-a systematic review and meta-analysis.

Yousef S, Elliott J, Manuel D, Colman I, Papadimitropoulos M, Hossain A, Leclair N, Wells GA.

Syst Rev. 2019 Aug 22;8(1):211. doi: 10.1186/s13643-019-1123-4.

13.

Nordic walking and standard exercise therapy in patients with chronic heart failure: A randomised controlled trial comparison.

Prince SA, Wooding E, Mielniczuk L, Pipe AL, Chan KL, Keast ML, Harris J, Tulloch HE, Mark AE, Cotie LM, Wells GA, Reid RD.

Eur J Prev Cardiol. 2019 Nov;26(16):1790-1794. doi: 10.1177/2047487319871215. Epub 2019 Aug 19. No abstract available.

PMID:
31426669
14.

Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review.

Elliott J, Kelly SE, Bai Z, Liu W, Skidmore B, Boucher M, So DYF, Wells GA.

Can J Cardiol. 2019 Aug;35(8):1039-1046. doi: 10.1016/j.cjca.2019.01.021. Epub 2019 Feb 6. Review.

PMID:
31376905
15.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, Büller HR, Rodger MA; MARVELOUS Collaborators.

BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.

16.

Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta-analysis.

Johnston A, Smith C, Zheng C, Aaron SD, Kelly SE, Skidmore B, Wells GA.

Clin Exp Allergy. 2019 Oct;49(10):1291-1305. doi: 10.1111/cea.13457. Epub 2019 Aug 6. Review.

PMID:
31295369
17.

Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure.

Manlucu J, Sharma V, Koehler J, Warman EN, Wells GA, Gula LJ, Yee R, Tang AS.

J Am Heart Assoc. 2019 Jul 16;8(14):e010998. doi: 10.1161/JAHA.118.010998. Epub 2019 Jul 11.

18.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].

Wells GA, Elliott J, Kelly S, Bai Z, Boucher M, Skidmore B, So D, Laplante S, Lee K.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.

19.

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review.

Elliott J, Kelly SE, Bai Z, Skidmore B, Boucher M, So DYF, Wells GA.

BMJ Open. 2019 Jun 16;9(6):e022271. doi: 10.1136/bmjopen-2018-022271.

20.

Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.

Elliott J, van Katwyk S, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D.

Pharmacoeconomics. 2019 Oct;37(10):1261-1276. doi: 10.1007/s40273-019-00816-2. Review.

PMID:
31201643
21.

Tramadol for osteoarthritis.

Toupin April K, Bisaillon J, Welch V, Maxwell LJ, Jüni P, Rutjes AW, Husni ME, Vincent J, El Hindi T, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2019 May 27;5:CD005522. doi: 10.1002/14651858.CD005522.pub3.

PMID:
31132298
22.

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.

Essebag V, AlTurki A, Proietti R, Healey JS, Wells GA, Verma A, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leather R, Ahmad K, Toal S, Sapp J, Sturmer M, Kavanagh K, Crystal E, Leiria TLL, Seifer C, Rinne C, Birnie D; BRUISE CONTROL Investigators.

Int J Cardiol. 2019 Aug 1;288:87-93. doi: 10.1016/j.ijcard.2019.04.066. Epub 2019 Apr 26.

PMID:
31056413
23.

Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells.

Bernatchez JA, Coste M, Beck S, Wells GA, Luna LA, Clark AE, Zhu Z, Hecht D, Rich JN, Sohl CD, Purse BW, Siqueira-Neto JL.

Viruses. 2019 Apr 20;11(4). pii: E365. doi: 10.3390/v11040365.

24.

The ART of conversation: feasibility and acceptability of a pilot peer intervention to help transition complex HIV-positive people from hospital to community.

Eaton AD, Chan Carusone S, Craig SL, Telegdi E, McCullagh JW, McClure D, Wilson W, Zuniga L, Berney K, Ginocchio GF, Wells GA, Montess M, Busch A, Boyce N, Strike C, Stewart A.

BMJ Open. 2019 Mar 30;9(3):e026674. doi: 10.1136/bmjopen-2018-026674.

25.

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.

Elliott J, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D.

Syst Rev. 2019 Mar 27;8(1):75. doi: 10.1186/s13643-019-0990-z.

26.

Spatial Abilities Training in Anatomy Education: A Systematic Review.

Langlois J, Bellemare C, Toulouse J, Wells GA.

Anat Sci Educ. 2019 Mar 6. doi: 10.1002/ase.1873. [Epub ahead of print]

PMID:
30839169
27.

Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.

Yadav K, Suh KN, Eagles D, Thiruganasambandamoorthy V, Wells GA, Stiell IG.

Am J Emerg Med. 2019 Feb 21. pii: S0735-6757(19)30107-X. doi: 10.1016/j.ajem.2019.02.023. [Epub ahead of print]

PMID:
30824277
28.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
29.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
30.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
31.

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.

Milman N, McConville E, Robson JC, Boonen A, Tugwell P, Wells GA, Chaudhuri D, Dawson J, Tomasson G, Ashdown S, Gebhart D, Lanier G, Peck J, McAlear CA, Kellom KS, Cronholm PF, Merkel PA.

J Rheumatol. 2019 Oct;46(10):1415-1420. doi: 10.3899/jrheum.181073. Epub 2019 Feb 1.

PMID:
30709951
32.

Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope.

Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, McRae AD, Arcot K, Nemnom MJ, Huang L, Mukarram M, Krahn AD, Wells GA, Taljaard M.

Circulation. 2019 Mar 12;139(11):1396-1406. doi: 10.1161/CIRCULATIONAHA.118.036088.

PMID:
30661373
33.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.

PMID:
30647191
34.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Sep;46(9):1159-1163. doi: 10.3899/jrheum.181081. Epub 2019 Jan 15.

PMID:
30647174
35.

Minimally Invasive coronary surgery compared to STernotomy coronary artery bypass grafting: The MIST trial.

Guo MH, Wells GA, Glineur D, Fortier J, Davierwala PM, Kikuchi K, Lemma MG, Mishra YK, McGinn J, Ramchandani M, Rabindra P, Nambala S, Chiu KM, Kiaii B, Gibson S, Ruel M.

Contemp Clin Trials. 2019 Mar;78:140-145. doi: 10.1016/j.cct.2019.01.006. Epub 2019 Jan 8.

PMID:
30634037
36.

The use of information and communication technologies by arthritis health professionals to disseminate a self-management program to patients: a pilot randomized controlled trial protocol.

De Angelis G, Brosseau L, Davies B, King J, Wells GA.

Digit Health. 2018 Dec 17;4:2055207618819571. doi: 10.1177/2055207618819571. eCollection 2018 Jan-Dec.

37.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH.

Europace. 2019 May 1;21(5):708-715. doi: 10.1093/europace/euy285.

PMID:
30535367
38.

Systematic reviews of clinical practice guidelines: a methodological guide.

Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA.

J Clin Epidemiol. 2019 Apr;108:64-76. doi: 10.1016/j.jclinepi.2018.11.030. Epub 2018 Dec 5.

PMID:
30529647
39.

Cannabis-based products for pediatric epilepsy: A systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA.

Epilepsia. 2019 Jan;60(1):6-19. doi: 10.1111/epi.14608. Epub 2018 Dec 4.

PMID:
30515765
40.

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Brinkhurst J, Wells GA.

CMAJ. 2018 Dec 3;190(48):E1406-E1413. doi: 10.1503/cmaj.180232.

41.

Postablation Atrial Fibrillation Burden and Patient Activity Level: Insights From the DISCERN AF Study.

Proietti R, Birnie D, Ziegler PD, Wells GA, Verma A.

J Am Heart Assoc. 2018 Dec 4;7(23):e010256. doi: 10.1161/JAHA.118.010256.

42.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
43.

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making.

Johnston A, Hsieh SC, Carrier M, Kelly SE, Bai Z, Skidmore B, Wells GA.

PLoS One. 2018 Nov 9;13(11):e0207410. doi: 10.1371/journal.pone.0207410. eCollection 2018.

44.

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.

Andrade JG, Champagne J, Deyell MW, Essebag V, Lauck S, Morillo C, Sapp J, Skanes A, Theoret-Patrick P, Wells GA, Verma A; EARLY-AF Study Investigators.

Am Heart J. 2018 Dec;206:94-104. doi: 10.1016/j.ahj.2018.05.020. Epub 2018 Oct 18.

PMID:
30342299
45.

Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation [Internet].

Wells GA, Smith C, Hossain A, Karsh J, Singh J, Hazlewood G, Tugwell P.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar.

46.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Review of the Clinical Impact of Treatment Duration [Internet].

Wells GA, Elliott J, Kelly S, So D, Boucher M, Bai Z, Liu W, Skidmore B.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug.

47.

Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians.

Couture EL, Farand P, Nguyen M, Allard C, Wells GA, Mansour S, Rinfret S, Afilalo J, Eisenberg M, Montigny M, Kouz S, Afilalo M, Lauzon C, Dery JP, L'Allier P, Schampaert E, Tardif JC, Huynh T.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E441-E448. doi: 10.1002/ccd.27877. Epub 2018 Sep 30.

PMID:
30269415
48.

Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants.

Avellaneda Matteo D, Wells GA, Luna LA, Grunseth AJ, Zagnitko O, Scott DA, Hoang A, Luthra A, Swairjo MA, Schiffer JM, Sohl CD.

Biochem J. 2018 Oct 22;475(20):3221-3238. doi: 10.1042/BCJ20180424.

49.

Cannabis for pediatric epilepsy: protocol for a living systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter B, Skidmore B, Alexander C, Repetski AE, McCoy B, Wells GA.

Syst Rev. 2018 Jul 18;7(1):95. doi: 10.1186/s13643-018-0761-2. Review.

50.

Validation and refinement of a clinical decision rule for the use of computed tomography in children with minor head injury in the emergency department.

Osmond MH, Klassen TP, Wells GA, Davidson J, Correll R, Boutis K, Joubert G, Gouin S, Khangura S, Turner T, Belanger F, Silver N, Taylor B, Curran J, Stiell IG; Pediatric Emergency Research Canada (PERC) Head Injury Study Group.

CMAJ. 2018 Jul 9;190(27):E816-E822. doi: 10.1503/cmaj.170406.

Supplemental Content

Loading ...
Support Center